In vitro characterization and clinical evaluation of skin hydration by two formulations mimicking the skin's natural components.


Journal

Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037

Informations de publication

Date de publication:
Apr 2022
Historique:
revised: 01 12 2021
received: 23 07 2021
accepted: 16 12 2021
entrez: 22 3 2022
pubmed: 23 3 2022
medline: 24 3 2022
Statut: ppublish

Résumé

We have developed innovative base formulations that were designed to mimic the skin with respect to its components and galenic structure. Components include water, proteins, lipids, sugars and minerals. We characterized formulations and their skin penetration using in vitro methods and evaluated their impact on skin hydration in a clinical trial. Scanning electron microscopy (SEM) imaging and X-ray diffraction were used to analyse formulations as well as formulation impact on the stratum corneum (SC) structure. Mass spectrometry imaging (MSI) was used to compare formulation ingredients with SC components and to detect their distribution in the skin. Clinical studies were performed to confirm effects on skin hydration and investigate potential adverse skin effects (irritation and sensitization). SEM and X-ray diffraction of the formulations showed that lipids were organized in sheets similar to SC lipids. MSI demonstrated similarities between formulation components and skin constituents, as well as a good penetration into the skin. The formulations did not modify the lamellar organization of the SC lipids, but they increased the relative proportion of the crystallized lipids and some of the amorphous lipids. In in vivo studies, a high level of hydration was maintained over 24 h after application with an intense and 'very good hydration'. Both formulations were shown to be non-(photo)sensitizers with excellent tolerance. Sensorial evaluation indicated the formulations were not oily or sticky and maintained the skin's suppleness over time. Formulations had a 'nude skin' touch and created a natural protective film. The two formulations were well-tolerated and increased skin hydration in clinical subjects, an effect that could contribute to the alleviation of sensitive skin. The formulations were shown to resemble the lipid organization of the stratum corneum, as well as penetrate the skin without disrupting the lipid lamella organization.

Sections du résumé

BACKGROUND BACKGROUND
We have developed innovative base formulations that were designed to mimic the skin with respect to its components and galenic structure. Components include water, proteins, lipids, sugars and minerals.
OBJECTIVES OBJECTIVE
We characterized formulations and their skin penetration using in vitro methods and evaluated their impact on skin hydration in a clinical trial.
METHODS METHODS
Scanning electron microscopy (SEM) imaging and X-ray diffraction were used to analyse formulations as well as formulation impact on the stratum corneum (SC) structure. Mass spectrometry imaging (MSI) was used to compare formulation ingredients with SC components and to detect their distribution in the skin. Clinical studies were performed to confirm effects on skin hydration and investigate potential adverse skin effects (irritation and sensitization).
RESULTS RESULTS
SEM and X-ray diffraction of the formulations showed that lipids were organized in sheets similar to SC lipids. MSI demonstrated similarities between formulation components and skin constituents, as well as a good penetration into the skin. The formulations did not modify the lamellar organization of the SC lipids, but they increased the relative proportion of the crystallized lipids and some of the amorphous lipids. In in vivo studies, a high level of hydration was maintained over 24 h after application with an intense and 'very good hydration'. Both formulations were shown to be non-(photo)sensitizers with excellent tolerance. Sensorial evaluation indicated the formulations were not oily or sticky and maintained the skin's suppleness over time. Formulations had a 'nude skin' touch and created a natural protective film.
CONCLUSIONS CONCLUSIONS
The two formulations were well-tolerated and increased skin hydration in clinical subjects, an effect that could contribute to the alleviation of sensitive skin. The formulations were shown to resemble the lipid organization of the stratum corneum, as well as penetrate the skin without disrupting the lipid lamella organization.

Identifiants

pubmed: 35315152
doi: 10.1111/jdv.17900
doi:

Substances chimiques

Oils 0
Water 059QF0KO0R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

21-29

Informations de copyright

© 2022 European Academy of Dermatology and Venereology.

Références

Misery L, Loser K, Ständer S. Sensitive skin. J Eur Acad Dermatol Venereol 2016; 30(S1): 2-8.
Sulzberger M, Worthmann AC, Holtzmann U et al. Effective treatment for sensitive skin: 4-t-butylcyclohexanol and licochalcone A. J Eur Acad Dermatol Venereol 2016; 30(Suppl 1): 9-17.
Berardesca E, Farage M, Maibach H. Sensitive skin: an overview. Int J Cosmet Sci 2013; 35(1): 2-8.
Willis CM, Shaw S, De Lacharrière O et al. Sensitive skin: an epidemiological study. Br J Dermatol 2001; 145(2): 258-263.
Modi D, Sharma H, Campbell G. Accelerate development of topical cream drug product using a common platform base formulation. Pharm Dev Technol 2020; 25(6): 767-778.
Simões A, Veiga F, Vitorino C. Developing cream formulations: Renewed interest in an old problem. J Pharm Sci 2019; 108(10): 3240-3251.
Spada F, Barnes TM, Greive KA. Skin hydration is significantly increased by a cream formulated to mimic the skin's own natural moisturizing systems. Clin Cosmet Investig Dermatol 2018; 11: 491-497.
Doucet J, Potter A, Baltenneck C, Domanov YA. Micron-scale assessment of molecular lipid organization in human stratum corneum using microprobe X-ray diffraction. J Lipid Res 2014; 55(11): 2380-2388.
Grégoire S, Luengo GS, Hallegot P et al. Imaging and quantifying drug delivery in skin - Part 1: Autoradiography and mass spectrometry imaging. Adv Drug Deliv Rev 2020; 153: 137-146.
Passarelli MK, Winograd N. Lipid imaging with time-of-flight secondary ion mass spectrometry (ToF-SIMS). Biochem Biophys Acta 2011; 1811(11): 976-990.
Sjövall P, Skedung L, Gregoire S et al. Imaging the distribution of skin lipids and topically applied compounds in human skin using mass spectrometry. Sci Rep 2018; 8(1): 16683.
Villaret A, Lestienne F, Vial F et al. Clinical evaluation of anesthetic-like effect of two dermocosmetic formulations containing Aquaphilus dolomiae extract-G3 in subjects with sensitive facial skin. J Eur Acad Dermatol Venereol 2021.

Auteurs

C Jacques (C)

Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France.

S Rattier (S)

Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France.

P Bianchi (P)

Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France.

T B Angerer (TB)

Luxembourg Institute of Science and Technology (LIST), Advanced Characterization platform, Materials Research and Technology, Belvaux, Luxembourg.

G Frache (G)

Luxembourg Institute of Science and Technology (LIST), Advanced Characterization platform, Materials Research and Technology, Belvaux, Luxembourg.

L Cattuzzato (L)

Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France.

L Perrin (L)

Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France.

A Villaret (A)

Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France.

V Duran (V)

Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France.

J Noharet (J)

Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France.

A Rouquier (A)

Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France.

S Bessou-Touya (S)

Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France.

C Bidan (C)

Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France.

H Duplan (H)

Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH